Skip to main content
TipRanks
Go Ultimate75% OFF

ME Therapeutics Holdings, Inc. (METX) Income Statement

10 Followers

ME Therapeutics Holdings, Inc. Income Statement

Last quarter (Q4 2024), ME Therapeutics Holdings, Inc.'s total revenue was ―. In Q4, ME Therapeutics Holdings, Inc.'s net income was $-312.04K. See ME Therapeutics Holdings, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementAug 24Aug 23Sep 22
―――
―――
―――
Depreciation and Amortization$ 39.00$ 49.00―
$ -1.29M$ -6.51M$ -57.46K
$ -1.37M$ -6.54M$ -60.28K
―――
―――
$ -1.29M$ -6.52M$ -57.46K
Per Share Metrics
Basic EPS―――
Diluted EPS―――
Weighted Average Shares Outstanding―――
Weighted Average Shares Outstanding (Diluted)―――

Currency in USD

ME Therapeutics Holdings, Inc. Earnings and Revenue History

-1.5M-1M-500K00 %0.4 %0.8 %1.2 %EarningsProfit Margin2024RevenueEarningsProfit Margin